Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$11.98 +0.23 (+1.96%)
As of 07/4/2025 12:03 PM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$11.98
C$11.98
50-Day Range
C$10.70
C$12.00
52-Week Range
C$9.20
C$12.13
Volume
200 shs
Average Volume
4,348 shs
Market Capitalization
C$137.02 million
P/E Ratio
19.44
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

RX Stock News Headlines

Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
Why Elon is funding the “Quantum Power Grid”
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year.
BioSyent Inc. (RX.V)
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of 2025. Since then, RX stock has increased by 8.9% and is now trading at C$11.98.

BioSyent Inc. (CVE:RX) announced its quarterly earnings results on Thursday, May, 25th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.08 by $0.02. The company had revenue of $3.82 million for the quarter, compared to analysts' expectations of $4.80 million. BioSyent had a net margin of 20.60% and a trailing twelve-month return on equity of 20.01%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
19.44
Forward P/E Ratio
17.25
P/E Growth
N/A
Net Income
C$7.02 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$34.06 million
Cash Flow
C$3.90 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.72

Miscellaneous

Free Float
N/A
Market Cap
C$137.02 million
Optionable
Not Optionable
Beta
0.93
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (CVE:RX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners